Direkt zum Inhalt
Merck

The 1,4-naphthoquinone scaffold in the design of cysteine protease inhibitors.

Bioorganic & medicinal chemistry (2007-05-29)
Cláudia Valente, Rui Moreira, Rita C Guedes, Jim Iley, Mohammed Jaffar, Kenneth T Douglas
ZUSAMMENFASSUNG

A series of 1,4-naphthoquinone derivatives diversely substituted at C-2, C-3, C-5 and C-8, prepared by reaction of amines, amino acids and alcohols with commercial 1,4-naphthoquinones, has been evaluated against papain and bovine spleen cathepsin B. These 1,4-naphthoquinone derivatives were found to be irreversible inhibitors for both cysteine proteases, with second-order rate constants, k(2), ranging from 0.67 to 35.4M(-1)s(-1) for papain, and from 0.54 to 8.03M(-1)s(-1) for cathepsin B. Some derivatives display a hyperbolic dependence of the first-order inactivation rate constant, k(obs), with the inhibitor concentration, indicative of a specific interaction process between enzyme and inhibitor. The chemical reactivity of the compounds towards cysteine as a model thiol is dependent on the naphthoquinone LUMO energy, whereas papain inactivation is not. The 1,4-naphthoquinone derivatives are inactive against the serine protease, porcine pancreatic elastase.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Menadion, crystalline
Sigma-Aldrich
1,4-Naphthochinon, 97%
Sigma-Aldrich
Menadion, meets USP testing specifications
Supelco
Menadion (K3), analytical standard
Sigma-Aldrich
Juglon, 97%
Sigma-Aldrich
1,4-Naphthochinon, purum, ≥96.5% (HPLC)